SZSE: 300143 - INKON Life Technology Co., Ltd.

Yield per half year: -14.74%
Dividend yield: 0.00%
Sector: Healthcare

INKON Life Technology Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 69.4 -100% 80.11 -100%
P/S 4.94 6.51 -24.08%
P/BV 5.1 3.96 28.91%
P/FCF 0 0 0%
Ev/Ebitda -11.87 11.85 -200.18%
Ev/S 5.15 5.98 -13.78%
Ev/FCF 0 0 0%
E/P -0.0864 0.0396 -318.21%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
3/10
9.45 16.34 -42.17% -21.1 -144.78%
ROE -36.6 11.95 -406.39%
ROA 3.19 5.4 -40.94%
ROIC 0 0 0%
ROS -46.44 16.23 -386.09%
ROCE 0 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.8971 14.63 -93.87% 1.36 -34.07%
Nеt Debt/Ebitda 0 0 0%
Debt/Ratio 0 0 0%
Debt/Equity 0 0 0%
Debt/Net Income -0.2419 3.6 -106.72%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.83 -100% 1.01 -100%
Number of years of dividend growth 1 1.44 -30.43%
DSI 1 0.9113 9.73%
Average dividend growth 0 10.4 -100%
Average percentage for 5 years 1.01 1.14 -11.42%
Average percentage for payments 70.69 44.8 57.79%
Difference from average difference in sector -1.83

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
156.71 61.43 155.1%
Growth impulse Ebitda in 5 years -444.86 158.62 -380.46%
Growth impulse Net Income in 5 years -114.28 66.93 -270.75%
Growth impulse FCF in 5 years 1009.91 248.41 306.55%
Growth impulse EPS in 5 years -112.18 73.29 -253.06%
IP Score
4.47/10

Similar companies

Shenzhen Neptunus Interlong Bio-technique Company Limited

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Yunnan Baiyao Group Co.,Ltd

Aier Eye Hospital Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription